Orchard Therapeutics competitorsClear all

Orchard Therapeutics's top competitors include Affinia Therapeutics, AID Genomics, Annexon Biosciences and Oxford BioTherapeutics.
Orchard Therapeutics
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
Affinia Therapeutics
Affinia Therapeutics
Affinia Therapeutics is a biotech company.
AID Genomics
AID Genomics
AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.
Annexon Biosciences
Annexon Biosciences
Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Founding Date
Founding Date
2015
Founding Date
2019
Founding Date
2013
Founding Date
2011
Founding Date
2004
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
London, GB HQ
Boston, US
Boston, US
Foster City, US
Menlo Park, US
Locations
Waltham, US HQ
Locations
Rehovot, IL HQ
Locations
South San Francisco, US HQ
Locations
Milton, GB HQ
San Jose, US
Employees
Employees
252
Employees
532% increase
Employees
398% increase
Employees
558% increase
Employees
284% increase
Alexa Website Rank
Alexa Website Rank
283846
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
317068
Alexa Website Rank
431847

Financial

Revenue (est.)
Revenue (est.)
£1.7m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£2.1m (FY, 2018)
Net income
Net income
(£184.4m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
(£6.5m) (FY, 2018)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 60m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 100m (12 months ago)
Latest funding round
$ 10m (almost 6 years ago)
Total funding raised
Total funding raised
$ 310.7m
Total funding raised
$ 60m
Total funding raised
N/A
Total funding raised
$ 179m
Total funding raised
$ 21.6m
For sources of this data, please see the company profile

View company profiles

Affinia Therapeutics
HQ
Waltham, US
Employees
53↑ 2% increase

Affinia Therapeutics is a biotech company.

View company
AID Genomics
HQ
Rehovot, IL
Employees
39↑ 8% increase

AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.

View company
Annexon Biosciences
HQ
South San Francisco, US
Employees
55↑ 8% increase

Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.

View company
Oxford BioTherapeutics
HQ
Milton, GB
Employees
28↑ 4% increase

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

View company